Product Description
lower price 95.0%~102.0% A white crystalline powder Penicillin V potassium salt 132-98-9
AI Product Description
*The following content is generated by AI and is for reference only.
Penicillin V Potassium, chemically known as Phenoxymethylpenicillin potassium salt, is a widely utilized semi-synthetic antibiotic belonging to the penicillin class. Its molecular formula is C16H17KN2O5S, and it carries the CAS registry number 1329-40-6. This compound typically appears as a white crystalline powder or granular solid, characterized by its high solubility in water compared to its acid counterpart, Penicillin V. The product specifications often indicate a purity range of 95.0% to 102.0%, ensuring consistent therapeutic efficacy for medical applications.
The primary utility of Penicillin V Potassium lies in its ability to treat bacterial infections caused by susceptible Gram-positive organisms. It functions by inhibiting bacterial cell wall synthesis, effectively disrupting the growth and reproduction of pathogens such as Streptococcus pyogenes, Streptococcus pneumoniae, and certain strains of Staphylococcus aureus. Clinically, it is frequently prescribed for mild to moderate infections including pharyngitis, tonsillitis, skin and soft tissue infections, and uncomplicated urinary tract infections. Its oral bioavailability makes it a preferred choice for outpatient treatment regimens where intravenous administration is unnecessary.
Beyond human medicine, this pharmaceutical grade ingredient serves critical roles in veterinary practice, treating similar infections in livestock and companion animals. The stability of the potassium salt form allows for reliable storage and distribution, maintaining potency under standard conditions. However, strict adherence to dosage guidelines is essential to prevent adverse reactions, particularly in patients with known hypersensitivity to beta-lactam antibiotics. The market demand for high-purity Penicillin V Potassium remains robust, driven by global healthcare needs and the continuous requirement for effective antimicrobial therapies against evolving bacterial resistance patterns. Manufacturers prioritize rigorous quality control to meet international pharmacopoeia standards, ensuring safety and efficacy for end-users across diverse medical sectors.